Figure 2 | Scientific Reports

Figure 2

From: Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer

Figure 2

Characterization of affi-F/AuNPs and Dox@affi-F/AuNPs. (A) Digital pictures of F/DNA1-AuNPs (1), affi-F/AuNPs (2) and AuNPs (3) after suspension in PBS buffer and overnight storage. (B) Agarose gel analysis of affi-F/AuNPs (UV-imaging of gel is on the left of the dividing line, and brightfield imaging of gel is on the right). Lane 1, F/DNA1-SH; Lane 2, AuNPs; Lane 3, F/DNA1-AuNPs; Lane 4, affi-F/AuNPs. (C) UV–Vis analysis of AuNPs, F/DNA1-AuNPs and affi-F/AuNPs. (D) Particle size distributions of AuNPs, affi-F/AuNPs and Dox@affi-F/AuNPs. (E) TEM images of AuNPs, affi-F/AuNPs and Dox@affi-F/AuNPs.

Back to article page